Matches in Wikidata for { <http://www.wikidata.org/entity/Q59252628> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q59252628 description "article scientifique publié en 2010" @default.
- Q59252628 description "scholarly article by A Grant et al published 2010 in Journal of the International AIDS Society" @default.
- Q59252628 description "wetenschappelijk artikel" @default.
- Q59252628 description "наукова стаття, опублікована у 2010" @default.
- Q59252628 name "Switching to a 'nuke-sparing' raltegravir/atazanavir combination: an individualised approach" @default.
- Q59252628 name "Switching to a 'nuke-sparing' raltegravir/atazanavir combination: an individualised approach" @default.
- Q59252628 type Item @default.
- Q59252628 label "Switching to a 'nuke-sparing' raltegravir/atazanavir combination: an individualised approach" @default.
- Q59252628 label "Switching to a 'nuke-sparing' raltegravir/atazanavir combination: an individualised approach" @default.
- Q59252628 prefLabel "Switching to a 'nuke-sparing' raltegravir/atazanavir combination: an individualised approach" @default.
- Q59252628 prefLabel "Switching to a 'nuke-sparing' raltegravir/atazanavir combination: an individualised approach" @default.
- Q59252628 P1433 Q59252628-EAC7FA83-321C-40AA-BA3E-7B23C3C6C5F0 @default.
- Q59252628 P1476 Q59252628-B077E1B6-7454-4E9B-A44C-DAE208FE90DC @default.
- Q59252628 P2093 Q59252628-13B7EE05-F980-4314-B6B2-0317F314BCEE @default.
- Q59252628 P2093 Q59252628-37E33E5A-34E6-4439-838C-C3F86DA95FBF @default.
- Q59252628 P2093 Q59252628-5CF0E00E-7AD4-4B71-B3E7-D7D93E36DEAD @default.
- Q59252628 P2093 Q59252628-A104F257-066E-416D-A12E-0BF020925266 @default.
- Q59252628 P2888 Q59252628-7524E13F-35EB-4B80-AC80-F53F603E95DE @default.
- Q59252628 P304 Q59252628-B705EDAC-C571-4421-BFCF-5E758E971110 @default.
- Q59252628 P31 Q59252628-16C1A3AF-D20C-47C1-AF2C-E4B49CE07E4F @default.
- Q59252628 P356 Q59252628-551FF8C9-5DC3-45B5-9933-59DAF791E1AC @default.
- Q59252628 P433 Q59252628-B13A7721-AB06-4132-A4DF-889A5CF9150B @default.
- Q59252628 P478 Q59252628-D307E39A-EEF2-4E08-B8A4-E1D5ED5B843B @default.
- Q59252628 P577 Q59252628-6A0C6CA3-3384-4CF9-8AEF-DF4760DE661C @default.
- Q59252628 P6179 Q59252628-640F1A62-B75A-44CD-BCF3-49FB2BBA41B5 @default.
- Q59252628 P8608 Q59252628-0EFBEE69-F609-4685-8A07-1E1A42AD6DE2 @default.
- Q59252628 P921 Q59252628-44A5C730-9C21-46CE-BCCA-D3E199293865 @default.
- Q59252628 P921 Q59252628-E194E8A6-E199-4977-A18B-A9E377C75746 @default.
- Q59252628 P932 Q59252628-DE4A1E8E-0D3B-48E4-B5A3-ACAA02660979 @default.
- Q59252628 P356 1758-2652-13-S4-P33 @default.
- Q59252628 P1433 Q6296158 @default.
- Q59252628 P1476 "Switching to a 'nuke-sparing' raltegravir/atazanavir combination: an individualised approach" @default.
- Q59252628 P2093 "A Grant" @default.
- Q59252628 P2093 "P Read" @default.
- Q59252628 P2093 "R Kulasegaram" @default.
- Q59252628 P2093 "Y Kamuntu" @default.
- Q59252628 P2888 1758-2652-13-s4-p33 @default.
- Q59252628 P304 "P33" @default.
- Q59252628 P31 Q13442814 @default.
- Q59252628 P356 "10.1186/1758-2652-13-S4-P33" @default.
- Q59252628 P433 "Suppl 4" @default.
- Q59252628 P478 "13" @default.
- Q59252628 P577 "2010-01-01T00:00:00Z" @default.
- Q59252628 P6179 "1045430667" @default.
- Q59252628 P8608 "release_od762jxwpvdvjoqxvwu7oxq6v4" @default.
- Q59252628 P921 Q18123741 @default.
- Q59252628 P921 Q423467 @default.
- Q59252628 P932 "3113035" @default.